팔로우
Ron Handels
Ron Handels
소속을 알 수 없음
maastrichtuniversity.nl의 이메일 확인됨
제목
인용
인용
연도
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ...
Alzheimer's & Dementia 15 (7), 888-898, 2019
2712019
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’Bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
2132018
Impact of molecular imaging on the diagnostic process in a memory clinic
R Ossenkoppele, ND Prins, YAL Pijnenburg, AW Lemstra, ...
Alzheimer's & Dementia 9 (4), 414-421, 2013
1952013
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 274-284, 2017
1512017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 285-295, 2017
1332017
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design
IA van Rossum, S Vos, R Handels, PJ Visser
Journal of Alzheimer's Disease 20 (3), 881-891, 2010
1322010
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
S Vos, I van Rossum, L Burns, D Knol, P Scheltens, H Soininen, ...
Neurobiology of aging 33 (10), 2272-2281, 2012
1002012
Health economic evaluation of treatments for Alzheimer′ s disease: impact of new diagnostic criteria
A Wimo, C Ballard, C Brayne, S Gauthier, R Handels, RW Jones, ...
Journal of internal medicine 275 (3), 304-316, 2014
912014
Needs and quality of life of people with middle-stage dementia and their family carers from the European Actifcare study. When informal care alone may not suffice
L Kerpershoek, M de Vugt, C Wolfs, B Woods, H Jelley, M Orrell, ...
Aging & mental health 22 (7), 897-902, 2018
792018
Determinants of care costs of patients with dementia or cognitive impairment
RLH Handels, CAG Wolfs, P Aalten, FRJ Verhey, JL Severens
Alzheimer Disease & Associated Disorders 27 (1), 30-36, 2013
592013
Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study
L Kerpershoek, M De Vugt, C Wolfs, H Jelley, M Orrel, B Woods, ...
BMC health services research 16 (1), 1-7, 2016
572016
Diagnosing Alzheimer's disease: a systematic review of economic evaluations
RLH Handels, CAG Wolfs, P Aalten, MA Joore, FRJ Verhey, JL Severens
Alzheimer's & Dementia 10 (2), 225-237, 2014
472014
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
432022
Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework
C Green, R Handels, A Gustavsson, A Wimo, B Winblad, A Sköldunger, ...
Alzheimer's & Dementia 15 (10), 1309-1321, 2019
432019
Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study
RLH Handels, P Aalten, CAG Wolfs, M OldeRikkert, P Scheltens, ...
BMC neurology 12 (1), 1-8, 2012
392012
Health-related quality of life in people with predementia Alzheimer’s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic …
F Landeiro, S Mughal, K Walsh, E Nye, J Morton, H Williams, I Ghinai, ...
Alzheimer's research & therapy 12 (1), 1-14, 2020
352020
Quality of life, care resource use, and costs of dementia in 8 European countries in a cross-sectional cohort of the actifcare study
RLH Handels, A Sköldunger, A Bieber, RT Edwards, ...
Journal of Alzheimer's Disease 66 (3), 1027-1040, 2018
342018
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
RLH Handels, SJB Vos, MG Kramberger, V Jelic, K Blennow, ...
Alzheimer's & Dementia 13 (8), 903-912, 2017
332017
Caregiver profiles in dementia related to quality of life, depression and perseverance time in the European Actifcare study: the importance of social health
EPCJ Janssen, M de Vugt, S Köhler, C Wolfs, L Kerpershoek, ...
Aging & mental health 21 (1), 49-57, 2017
312017
Cost-utility of using Alzheimer’s disease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia
RLH Handels, A Wimo, R Dodel, MG Kramberger, PJ Visser, ...
Journal of Alzheimer's Disease 60 (4), 1477-1487, 2017
302017
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20